Clinical Reviews in Allergy

, Volume 3, Issue 1, pp 95–116 | Cite as

Urticaria and angioedema

  • Barbara A. Burrall
  • Arthur C. Huntley


Dermatol Urticaria Angioedema Allergy Clin Immunol Chronic Urticaria 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Monroe EW: Urticaria and urticarial vasculitis. Med Clin North Am 64:867–882, 1980PubMedGoogle Scholar
  2. 2.
    Sunder CDR, Balsam MJ, Vengrow MI: Neurologic manifestations of angioedema. JAMA 247:2005–2007, 1982PubMedGoogle Scholar
  3. 3.
    Lever WF, Schaumburg-Lever G: Histopathology of the skin. Philadelphia, J.B. Lippincott, 1983, p 167Google Scholar
  4. 4.
    Natbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP: Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 71:177–183, 1983PubMedGoogle Scholar
  5. 5.
    Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM: Definition and antagonism of histamine H2-receptors. Nature 236:385–390, 1972PubMedGoogle Scholar
  6. 6.
    Wintroub BU, Soter NA; Biology of the mast cell and its role in cutaneous inflammation. Springer Semin Immunopathol 4:55–63, 1981PubMedGoogle Scholar
  7. 7.
    Guin JD, treatment of urticaria. Med Clin North Am 66:831–849, 1982PubMedGoogle Scholar
  8. 8.
    Lewis T: The blood vessels of the human skin and their response. London, Shaw and Sons, 1927Google Scholar
  9. 9.
    Austen KF: Biologic implications of the structural and functional characteristics of the chemical mediators of immediate-type hypersensitivity. Harvey Lect Ser 73:93–161, 1979Google Scholar
  10. 10.
    Bach MK: Mediators of anaphylaxis and inflammation. Annu Rev Microbiol 36:371–413, 1982PubMedGoogle Scholar
  11. 11.
    Kellermeyer RW, Graham RC: Kinins—Possible physiologic and pathologic roles in man. N Engl J Med 279:754–759, 1968PubMedGoogle Scholar
  12. 12.
    Beall GN: Urticaria: A review of laboratory and clinical observations. Medicine 43:131–146, 1964PubMedGoogle Scholar
  13. 13.
    Juhlin L, Michaelsson G: Cutaneous reactions to kallikrein, bradykinin, and histamine in healthy subjects and in patients with urticaria. Acta Derm Venereol [Suppl] (Stockh) 49:26–36, 1969Google Scholar
  14. 14.
    Dor PJ, Vervloet D, Sapene M, Andrac L, Bonerandi JJ, Charpin J: Induction of late cutaneous reaction by kallikrein injection: Comparison with allergic-like late responses to compound 48/80. J Allergy Clin Immunol 71:363–370, 1983PubMedGoogle Scholar
  15. 15.
    Juhlin L, Michaelsson G: Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol [Suppl] (Stockh) 49:251–261, 1969Google Scholar
  16. 16.
    Mathews KP: Management of urticaria and angioedema. J Allergy Clin Immunol 66:347–357, 1980PubMedGoogle Scholar
  17. 17.
    Solomon LM, Juhlin L, Kirschenbaum MB: Prostaglandin on cutaneous vasculature. J Invest Dermatol 51:280–282, 1968PubMedGoogle Scholar
  18. 18.
    Monroe EW: Urticaria. Int J Dermatol 2:32–41, 1981Google Scholar
  19. 19.
    Monroe EW, Jones HE: Urticaria. Arch Dermatol 113:80–90, 1977PubMedGoogle Scholar
  20. 20.
    Buddy S, Gigli I, Austen F: The complement system of man. N Engl J Med 287:489–494, 1972Google Scholar
  21. 21.
    James J, Warin RP: Chronic urticaria: The effect of aspirin. Br J Dermatol 82:204–205, 1970PubMedGoogle Scholar
  22. 22.
    Doeglas HMG: Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br J Dermatol 93:135–144, 1975PubMedGoogle Scholar
  23. 23.
    Camp RDR, Coutts AA, Greaves MW, Kay ABB, Walport MJ: Responses of human skin to intradermal injections of leukotrienes C4, D4, and B4. J Invest Dermatol 78:329, 1982Google Scholar
  24. 24.
    Marx JL: The leukotrienes in allergy and inflammation. Science 215:1380–1383, 1982PubMedGoogle Scholar
  25. 25.
    Weiss J, Woodrow D, Jeffrey M, Coles N, McFadden ER, Welter P, Corey EJ, Lewis RA, Austen KF: Bronchoconstrictor effects of leukotriene C in humans. Science 216:196–198, 1982PubMedGoogle Scholar
  26. 26.
    Moss J, De Mello MC, Vaughan M, Beaver MA: Effect of salicylates on histamine and 1-histidine metabolism. Inhibition of imidazoleacetate phosphoribosyl transferase. J Clin Invest 58:137, 1976PubMedGoogle Scholar
  27. 27.
    Michaelsson G, Juhlin L: Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 88:525–532, 1973PubMedGoogle Scholar
  28. 28.
    Van Arsdel PP: Allergy and adverse drug reactions. J Am Acad Dermatol 6:833–845, 1982Google Scholar
  29. 29.
    Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ: Desensitization of patients allergic to penicillin using orally administered -lactam antibiotics. J Allergy Clin Immunol 69:275–282, 1982PubMedGoogle Scholar
  30. 30.
    Luciano JR, Tarpay M: Penicillin allergy. South Med J 69:118–120, 1976PubMedGoogle Scholar
  31. 31.
    Coleman WP, Swineford O: Penicillin hypersensitivity: A brief review and report of an extreme case. Va Med Mo 83:6, 1956Google Scholar
  32. 32.
    Fellner MJ: Immunology of skin diseases. New York, Elsevier, 1980, pp 100–115Google Scholar
  33. 33.
    Green GR, Rosenblum AH, Sweet LC: Evaluation of penicillin hypersensitivity: Value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. J Allergy Clin Immunol 60:339–345, 1977PubMedGoogle Scholar
  34. 34.
    Sullivan TJ, Wedner HJ, Shatz GS, Yecies LD, Parker CW: Skin testing to detect penicillin allergy. 68:171–180, 1981Google Scholar
  35. 35.
    Green GR, Peters GA, Geraci JE: Treatment of bacterial endocarditis in patients with penicillin hypersensitivity. Ann Intern Med 67:235–249, 1967PubMedGoogle Scholar
  36. 36.
    Gorevic PD, Levine BB: Desensitization of anaphylactic hypersensitivity specific for the penicilloate minor determinant of penicillin and carbenicillin. J Allergy Clin Immunol 68:267–272, 1981PubMedGoogle Scholar
  37. 37.
    Naclerio R, Mizrahi EA, Adkinson NF: Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 71:294–301,1983PubMedGoogle Scholar
  38. 38.
    Waldbott GL, Merkle K: Urticaria due to pollen. Ann Allergy 10:30–35, 1952PubMedGoogle Scholar
  39. 39.
    Tannenbaum H: Angioedema provoked by olfactory stimuli. Can Med Assoc J 127:735–736, 1982PubMedGoogle Scholar
  40. 40.
    Neumann HAM, Berretty PJM, Folmer SCCR, Cormane RH: Hepatitis B surface antigen deposition in the blood vessel walls of urticarial lesions in acute hepatitis B. Br J Dermatol 104:383–387, 1981PubMedGoogle Scholar
  41. 41.
    McElgunn PSJ: Dermatologie manifestations of hepatitis B virus infection. J Am Acad Dermatol 8:539–548, 1983PubMedGoogle Scholar
  42. 42.
    Cowdrey SC, Reynolds JS: Acute urticaria in infectious mononucleosis. Ann Allergy 27:182–187, 1969PubMedGoogle Scholar
  43. 43.
    Wands JR, Perroto JL, Isselbocher KJ: Circulating immune complexes and complement sequence activation in infectious mononucleosis. Am J Med 60:269–272, 1976PubMedGoogle Scholar
  44. 44.
    Weary PE, Guerrant JL: Chronic urticaria in association with dermatophytosis. Arch Dermatol 95:400–401, 1967PubMedGoogle Scholar
  45. 45.
    James J, Warin RP: An assessment of the role ofCandida albicans and food yeasts in chronic urticaria. Br J Dermatol 84:227–237, 1971PubMedGoogle Scholar
  46. 46.
    Ahmed AR: Immunology of human dermatophyte infections. Arch Dermatol 118:521–525, 1982PubMedGoogle Scholar
  47. 47.
    Williams RE, Santiago SM, Klaustermeyer WB: Urticaria associated with maxillary sinusitis. Ann Allergy 47:446–448, 1981PubMedGoogle Scholar
  48. 48.
    Pollowitz JA: Acute urticaria associated with shigellosis. A case report. Ann Allergy 45:302–303, 1980PubMedGoogle Scholar
  49. 49.
    Ramirez DA, Summers RJ, Evans R: The diagnosis of hymenoptera hypersensitivity. Ann Allergy 47:303–306, 1981PubMedGoogle Scholar
  50. 50.
    Leech SH, Kumar P: Cyclic urticaria. Ann Allergy 46:201–203, 1981PubMedGoogle Scholar
  51. 51.
    Braverman IM: Urticaria as a sign of internal disease. Postgrad Med J 41:450–454, 1967Google Scholar
  52. 52.
    Provost TT, Zone JJ, Synkowski D, Maddison PJ, Reichlin M: Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlation with clinical and serological abnormalities. J Invest Dermatol 75:495–499, 1980PubMedGoogle Scholar
  53. 53.
    Horvath A, Kramer M, Ablonczy E: Clinical evaluation and pathomechanism of urticarialike skin eruption in systemic lupus erythematosus. Acta Derm Venereol [Suppl] (Stockh) 62:253–256, 1981Google Scholar
  54. 54.
    McDuffie FC, Sams WM, Maldonado JE, Andreini PH, Conn DL, Samayoa EA: Hypocomplementemia with cutaneous vasculitis and arthritis. Mayo Clin Proc 48:340–348, 1973PubMedGoogle Scholar
  55. 55.
    Soter NA, Austen KF, Gigli I: Urticaria and arthralgias as manifestations of necrotizing angiitis (vasculitis). J Invest Dermatol 63:485–490, 1974PubMedGoogle Scholar
  56. 56.
    Monroe EW: Urticarial vasculitis: An updated review. J Am Acad Dermatol 5:88–95, 1981PubMedGoogle Scholar
  57. 57.
    Small P, Barrett D, Champlin E: Chronic urticaria and vasculitis. Ann Allergy 48:172–174, 1982PubMedGoogle Scholar
  58. 58.
    Soter NA: Chronic urticaria as a manifestations of necrotizing venulitis. N Engl J Med 296:1440–1442, 1977PubMedGoogle Scholar
  59. 59.
    Feig PV, Soter NA, Yager HM, Caplan L, Rosen S: Vasculitis with urticaria, hypocomplementemia, and multiple system involvement. JAMA 236:2065–2068, 1976PubMedGoogle Scholar
  60. 60.
    Mathison DA, Arroyave CM, Bhat KN, Hurewitz DS, Marnell DJ: Hypocomplementemia in chronic idiopathic urticaria. Ann Intern Med 86:534–538, 1977PubMedGoogle Scholar
  61. 61.
    Monroe EW, Schultz CI, Maize JC, Jordon RE: Vasculitis in chronic urticaria: An immunopathologic study. J Invest Dermatol 76:103–107, 1981PubMedGoogle Scholar
  62. 62.
    Millns JL, Randle HW, Solley GO, Dicken CH: The therapeutic response of urticarial vasculitis to indomethacin. J Am Acad Dermatol 3:349–355, 1980PubMedGoogle Scholar
  63. 63.
    Soter NA, Wasserman SI: Clinical manifestations, pathogenesis, and therapeutic approaches in urticaria/angioedema. Dermatol Dig 18:17–32, 1979Google Scholar
  64. 64.
    Marder RJ, Rent R, Choi EYC, Gewurz H: C1q deficiency associated with urticarial-like lesions and cutaneous vasculitis. Am J Med 61:560–565, 1976PubMedGoogle Scholar
  65. 65.
    Von Krogh G, Maibach HI: The contact urticaria syndrome—An updated review. J Am Acad Dermatol 5:328–342, 1981Google Scholar
  66. 66.
    Maibach HI, Johnson HL: Contact urticaria syndrome. Arch Dermatol 111:726–730, 1975PubMedGoogle Scholar
  67. 67.
    Lahti A: Non-immunologic contact urticaria. Acta Derm Venereol [Suppl] (Stockh) 91:1–49, 1980Google Scholar
  68. 68.
    Thach JR: Allergic contact urticaria to benzoyl peroxide. Cutis 29:187–188, 1982Google Scholar
  69. 69.
    Winton GB, Lewis CW: Contact urticaria. Int J Dermatol 21:573–578, 1982PubMedGoogle Scholar
  70. 70.
    Roupe G, Strannegard O: Anaphylactic shock elicited by topical bacitracin. Arch Dermatol 100:450–452, 1969PubMedGoogle Scholar
  71. 71.
    Temesvan E, Soos G, Podany B, Kovacs I, Nemeth I: Contact urticaria provoked by balsam of Peru. Contact Dermatitis 4:65–68, 1978Google Scholar
  72. 72.
    Forsbeck M, Skog E: Immediate reactions to patch tests with balsam of Peru. Contact Dermatitis 3:201–205, 1977PubMedGoogle Scholar
  73. 73.
    Mathias CGT, Chappler RR, Maibach HI: Chronic urticaria from cinnamic aldehyde. Arch Dermatol 116:74–76, 1980PubMedGoogle Scholar
  74. 74.
    Warin RP, Higgs ER: Acute and recurrent abdominal pain due to hereditary angio-edema. Br Med J 284:1912, 1982Google Scholar
  75. 75.
    Brettle RP, Dunmow RE, Milne LA, Yap PL: Angioneurotic oedema in the elderly. Scott Med J 27:309–311, 1982PubMedGoogle Scholar
  76. 76.
    Gigli I: Hereditary angioedema. J Invest Dermatol 60:516–521, 1973PubMedGoogle Scholar
  77. 77.
    Nagumo M, Kimura T, Yoshimura S, Enomoto S: Immunologic studies on angioneurotic edema. J Oral Med 37:3–7, 1982PubMedGoogle Scholar
  78. 78.
    Quastel M, Harrison R, Cicardi M, Alper CA, Rosen FS: Behavior in vivo of and patients with hereditary angioneurotic edema. J Clin Invest 71:1041–1046, 1983PubMedGoogle Scholar
  79. 79.
    Curd JG, Yelvington M, Ziccardi RJ, Mathison DA, Griffin JH: Purification and characterization of two functionally distinct forms of Q inhibitor from a patient with angioedema. Clin Exp Immunol 45:261–270, 1981PubMedGoogle Scholar
  80. 80.
    Cohen SH, Koethe SM, Kozin F, Rodey G, Arkins JA, Fink JN: Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. J Allergy Clin Immunol 62:217–221, 1978PubMedGoogle Scholar
  81. 81.
    Frank MM, Gelfand JA, Atkinson JP: Hereditary angioedema: The clinical syndrome and its management. Ann Intern Med 84:580–593, 1976PubMedGoogle Scholar
  82. 82.
    Gelfand JA, Sherins RJ, Alling DW, Frank MM: Treatment of hereditary angioedema with danazol. N Engl J Med 295:1444–1448, 1976PubMedGoogle Scholar
  83. 83.
    Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM: Long-term therapy of hereditary angioedema with danazol. Ann Intern Med 93:809–812, 1980PubMedGoogle Scholar
  84. 84.
    Gadek JE, Hosea SW, Gelfand JA, Frank MM: Response of variant hereditary angioedema phenotypes to danazol therapy. J Clin Invest 64:280–286, 1979PubMedGoogle Scholar
  85. 85.
    Kovary PM, Opterkuch W, Echternacht-Happle K, Happle R: Effect of danazol on dysfunctional C1 inhibitor in a patient with angioedema. Arch Dermatol Res 270:119–122, 1981PubMedGoogle Scholar
  86. 86.
    Pence HL, Evans R, Guernsey LH, Gerhard RC: Prophylactic use of epsilon aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema. J Allergy Clin Immunol 53:298–302, 1974PubMedGoogle Scholar
  87. 87.
    Jaffe CJ, Atkinson JP, Gelfand JA, Frank MM: Hereditary angioedema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J Allergy Clin Immunol 55:386–393, 1975PubMedGoogle Scholar
  88. 88.
    Czarnetzki BM, Behrendt H: Urticaria pigmentosa:. Clinical picture and response to oral disodium chromoglycate. Br J Dermatol 105:563–567, 1981PubMedGoogle Scholar
  89. 89.
    DiBacco RS, Delceo VA: Mastocytosis and the mast cell. J Am Acad Dermatol 7:709–722, 1982PubMedGoogle Scholar
  90. 90.
    Fine JD: Mastocytosis. Int J Dermatol 19:117–123, 1980PubMedGoogle Scholar
  91. 91.
    Parker F, Odland GF: The mastocytosis syndrome. In Fitzpatrick TB, Eisen AZ, Wolff K, Freedburg IM, Austen KF (eds): Dermatology in general medicine. New York, McGraw-Hill, 1979, p 781Google Scholar
  92. 92.
    Guillet GY, Dore N, Maleville J: Heparin liberation in urticaria pigmentosa. Arch Dermatol 118:532–533, 1982PubMedGoogle Scholar
  93. 93.
    Soter NA, Austen KF, Wasserman SI: Oral disodium chromoglycate in the treatment of systemic mastocytosis. N Engl J Med 301:465–469, 1979PubMedGoogle Scholar
  94. 94.
    Berg MJ, Bernhard H, Schentag JJ: Cimetadine in systemic mastocytosis. Drug Intell Clin Pharm 15:180–183, 1981PubMedGoogle Scholar
  95. 95.
    Gerrard JW, Ko C: Urticaria pigmentosa: Treatment with cimetadine and chlorpheniramine. J Pediatr 94:843–844, 1979PubMedGoogle Scholar
  96. 96.
    Hirschowitz BI, Groarke JF: Effect of cimetadine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 90:769–771, 1979PubMedGoogle Scholar
  97. 97.
    Roberts LJ, Sweetman BJ, Lewis RA, Austen KF, Oates JA: Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 303:1400–1404, 1980PubMedGoogle Scholar
  98. 98.
    Christophers E, Honigsmann H, Wolff K, Langner A: PUVA—Treatment of urticaria pigmentosa. Br J Dermatol 98:701–702, 1978PubMedGoogle Scholar
  99. 99.
    Granerus G, Roupe G, Swanbeck G: Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa. J Invest Dermatol 76:1–3, 1981PubMedGoogle Scholar
  100. 100.
    Soter NA, Wasserman SI: Physical urticaria/angioedema: An experimental model of mast cell activation in humans. J Allergy Clin Immunol 66:358–365, 1980PubMedGoogle Scholar
  101. 101.
    Jorizzo JL, Smith EB: The physical urticarias. Arch Dermatol 118:194–201, 1982PubMedGoogle Scholar
  102. 102.
    Gorevic PD, Kaplan AP: The physical urticarias. Int J Dermatol 19:417–435, 1980PubMedGoogle Scholar
  103. 103.
    Garafalo J, Kaplan AP: Histamine release and therapy of severe dermatographism. J. Allergy Clin. Immunol. 68:103–105, 1981PubMedGoogle Scholar
  104. 104.
    Ryan TJ, Shim-Young N, Turk JL: Delayed pressure urticaria. Br J Dermatol 80:485–490, 1968PubMedGoogle Scholar
  105. 105.
    Estes SA, Yung CW: Delayed pressure urticaria: An investigation of some parameters of lesion induction. J Am Acad Dermatol 5:25–31, 1981PubMedGoogle Scholar
  106. 106.
    Houser DD, Arbesman CE, Koji I, Wicher K: Cold urticaria. Immunologic studies. Am J Med 49:23–33, 1970PubMedGoogle Scholar
  107. 107.
    Aoki T, Horiko T, Akimoto T, Generalized cold urticaria: Detection of heat-sensitive passive transfer substance active at moderate temperature. Clin Exp Dermatol 7:377–386, 1982PubMedGoogle Scholar
  108. 108.
    Lawrence CM, Jorizzo JL, Kobza-Black A, Coutts A, Greaves MW: Cholinergic urticaria with associated angio-edema. Br J Dermatol 105:543–550, 1981PubMedGoogle Scholar
  109. 109.
    Soter NA, Wasserman SI, Austen KF, McFadden ER: Release of mast cell mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 302:604–608, 1980PubMedGoogle Scholar
  110. 110.
    Kaplan AP, Natbony SF, Tawil AP, Fruchter L, Foster M: Exercise induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol 68:319–324, 1981PubMedGoogle Scholar
  111. 111.
    Davis RS, Remigio LK, Schocket AL, Bock SA: Evaluation of a patient with both aquagenic and cholinergic urticaria. J Allergy Clin Immunol 68:479–483, 1981PubMedGoogle Scholar
  112. 112.
    Commens CA, Greaves MW: Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol 98:47–51, 1978PubMedGoogle Scholar
  113. 113.
    Sheffer AL, Soter NA, McFadden ER, Austen KF: Exercise-induced anaphylaxis: A distinct form of physical allergy. J Allergy Clin Immunol 71:311–316, 1983PubMedGoogle Scholar
  114. 114.
    Kidd JM, Cohen SH, Sosman AJ, Fink JN: Food-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol 71:407–411, 1983PubMedGoogle Scholar
  115. 115.
    Novey HS, Fairshter RD, Salness K, Simon RA, Curd JG: Postprandial exercise-induced anaphylaxis. J Allergy Clin Immunol 71:498–504, 1983PubMedGoogle Scholar
  116. 116.
    Epstein JH: Phototoxicity and photoallergy in man. J Am Acad Dermatol 8:141–147, 1983PubMedGoogle Scholar
  117. 117.
    Ravits M, Armstrong RB, Harber LC: Solar urticaria. Arch Dermatol 118:228–231, 1982PubMedGoogle Scholar
  118. 118.
    Soter NA, Wasserman SI, Pathak MA, Austen KF: Solar urticaria: Release of mast cell mediators into the circulation after experimental challenge. J Invest Dermatol 72:282, 1979Google Scholar
  119. 119.
    Kobza A, Ramsay CA, Magnus LA: Oral β-carotene therapy in actinic reticuloid and solar urticaria. Br J Dermatol 88:157–166, 1973PubMedGoogle Scholar
  120. 120.
    Ramsay CA: Solar urticaria treatment by inducing tolerance to artificial radiation and natural light. Arch Dermatol 113:1222–1225, 1977PubMedGoogle Scholar
  121. 121.
    Parrish JA, Jaenicke KF, Morison WL, Momtaz K, Shea C: Solar urticaria: Treatment with PUVA and mediator inhibitors. Br J Dermatol 106:575–580, 1982PubMedGoogle Scholar
  122. 122.
    Greaves MW, Sneddon IB, Smith AK, Stanworth DR: Heat urticaria. Br J Dermatol 90:289–292, 1974PubMedGoogle Scholar
  123. 123.
    Atkins PC, Zweiman B: Mediator release in local heat urticaria. J Allergy Clin Immunol 68:286–289, 1981PubMedGoogle Scholar
  124. 124.
    Toth-Kasa I, Jancso G, Obal F, Husz S, Simon N: Involvement of sensory nerve endings in cold and heat urticaria. J Invest Dermatol 80:34–36, 1983PubMedGoogle Scholar
  125. 125.
    Daman L, Lieberman P, Ganier M, Hashimoto K: Localized heat urticaria. J Allergy Clin Immunol 61:273–278, 1978PubMedGoogle Scholar
  126. 126.
    Leigh IM, Ramsay CA: Localized heat urticaria treated by inducing tolerance to heat. Br J Dermatol 92:191–194, 1975PubMedGoogle Scholar
  127. 127.
    Greaves MW: Urticarias: New approaches to investigation and management. Australas J Dermatol 22:47–52, 1981PubMedGoogle Scholar
  128. 128.
    Sibbald RG, Kobza-Black A, Eady RAJ, James M, Greaves MW: Aquagenic urticaria: Evidence of cholinergic and histaminergic basis. Br J Dermatol 105:297–302, 1981PubMedGoogle Scholar
  129. 129.
    Patterson R, Mellies CJ, Blanker ML, Pruzansky JJ: Vibratory angioedema: A hereditary type of physical hypersensitivity. J Allergy Clin Immunol 50:174–182, 1972PubMedGoogle Scholar
  130. 130.
    Wener MH, Metzger WJ, Simon RA: Occupationally acquired vibratory angioedema with secondary carpal tunnel syndrome. Ann Intern Med 98:44–46, 1983PubMedGoogle Scholar
  131. 131.
    Kaplan AP, Beaven MA: In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol 67:327–332, 1976PubMedGoogle Scholar
  132. 132.
    Gibson A, Clancy R: Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors. Clin Allergy 10:699–704, 1980PubMedGoogle Scholar
  133. 133.
    Lee M, Gentry AF, Schwartz R: Tartrazine-containing drugs. Drug Intell Clin Pharm 15:782–788, 1981PubMedGoogle Scholar
  134. 134.
    Douglas WW: Autacoids. In Gilman AG, Goodman LS, Gilman A (eds): The pharmacologic basis of therapeutics, 6th edition. New York, Macmillan, 1980, pp 622–632Google Scholar
  135. 135.
    Fisher AA: The antihistamines. J Am Acad Dermatol 3:303–305, 1980PubMedGoogle Scholar
  136. 136.
    Shelley WB: Commentary: Antihistamines and the treatment of urticaria. Arch Dermatol 119:442–444, 1983PubMedGoogle Scholar
  137. 137.
    Greaves M, Marks R, Robertson I: Receptors for histamine in human skin blood vessels: A review. Br J Dermatol 97:225–229, 1977PubMedGoogle Scholar
  138. 138.
    Summers R, Sigler R, Shelhamer JH, Kaliner M: Effects of infused histamine on asthmatic and normal subjects: Comparison of skin test responses. J Allergy Clin Immunol 67:456–464, 1981PubMedGoogle Scholar
  139. 139.
    Rebhun J: Hypothetical role of H-2 blockers in chronic urticaria. Ann Allergy 47:440–442, 1981PubMedGoogle Scholar
  140. 140.
    Harvey RP, Wegs J, Schocket AL: A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 68:262–266, 1981PubMedGoogle Scholar
  141. 141.
    Monroe EW, Cohen SH, Kalbfleisch J, Schultz CI, Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 117:404–407, 1981PubMedGoogle Scholar
  142. 142.
    Phanuphak P, Schocket A, Kohler PF: Treatment of chronic idiopathic urticaria with combined H1, and H2 blockers. Clin Allergy 8:429–433, 1978PubMedGoogle Scholar
  143. 143.
    Ortolani C, Cornelli U, Bellani M, Pastorello E, Zanussi C: Sodium chromoglycate and provocation tests in chronic urticaria. Ann Allergy 48:50–52, 1982PubMedGoogle Scholar
  144. 144.
    Saihan EM: Ketotifen and terbutaline in urticaria. Br J Dermatol 104:205–206, 1981PubMedGoogle Scholar
  145. 145.
    Spangler DL, Vanderpool GE, Carroll MS, Tinkelman DG: Terbutaline in the treatment of chronic urticaria. Ann Allergy 45:246–247, 1980PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1985

Authors and Affiliations

  • Barbara A. Burrall
    • 1
  • Arthur C. Huntley
    • 1
  1. 1.From the Dermatology DepartmentUniversity of California at DavisDavis

Personalised recommendations